Repurposing FDA-Approved Antimalarial Drugs: Mefloquine as a Promising Multi-Targeted Therapeutic for Non-Small Cell Lung Cancer: Repurposing Antimalarials: Mefloquine for Multi-Targeted NSCLC Therapy. (2025). Indian Journal of Chemistry (IJC), 64(7), 730-745. https://doi.org/10.56042/ijc.v64i7.16642